Table 1 Clinicopathological features
From: Study of the tumor microenvironment during breast cancer progression
Parameters | Normal | Stage I | Stage II | Stage III | Stage IV |
|---|---|---|---|---|---|
Number of cases | 11 | 14 | 15 | 15 | 10 |
Age (years) (mean ± SEM) | 40 ± 2.6 | 48 ± 2 | 53 ± 3 | 43 ± 2.6 | 55 ± 3.5 |
Menopausal status | |||||
Pre | 84 | 84.6 | 55.5 | 73 | 62.5 |
Post | 16 | 15.4 | 44.5 | 27 | 37.5 |
Type | |||||
IDC | NA | 100 | 93 | 87.5 | 100 |
ILC | NA | 0 | 7 | 12.5 | 0 |
Hormone status | |||||
ER Positive | NA | 77 | 53 | 80 | 62.5 |
PR Positive | NA | 54 | 44 | 80 | 50 |
Her2/neu positive | NA | 23 | 37.5 | 53 | 37.5 |
p53 positive | NA | 70 | 30 | 33 | 33 |